The examination of the efficacy by adverse reaction changing the treatment with Oxybutynin or Mirabegron on the patient who cannot go on treatment with anticholinergic agent
Not Applicable
- Conditions
- Overactive bladder
- Registration Number
- JPRN-UMIN000019736
- Lead Sponsor
- Department of Urology, Shiga University of medical science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
contraindication of the medicine acute urinary retension within 12 months residual urine over 100mL urinary infection a1 blacker within 4 weeks
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method